Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Database
Language
Publication year range
1.
Allergy ; 74(4): 685-697, 2019 04.
Article in English | MEDLINE | ID: mdl-30402955

ABSTRACT

BACKGROUND: Chitinase 3-like 1 protein (CHI3L1) (YKL-40 in humans and breast regression protein [BRP]-39 in mice) is required for optimal allergen sensitization and Th2 inflammation in various chronic inflammatory diseases including asthma. However, the role of CHI3L1 in airway inflammation induced by respiratory viruses has not been investigated. The aim of this study was to investigate the relationship between CHI3L1 and airway inflammation caused by respiratory syncytial virus (RSV) infection. METHODS: We measured YKL-40 levels in human nasopharyngeal aspirate (NPA) from hospitalized children presenting with acute respiratory symptoms. Wild-type (WT) and BRP-39 knockout (KO) C57BL/6 mice were inoculated with live RSV (A2 strain). Bronchoalveolar lavage fluid and lung tissue samples were obtained on day 7 after inoculation to assess lung inflammation, airway reactivity, and expression of cytokines and BRP-39. RESULTS: In human subjects, YKL-40 and IL-13 levels in NPA were higher in children with RSV infection than in control subjects. Expression of BRP-39 and Th2 cytokines, IL-13 in particular, was increased following RSV infection in mice. Airway inflammation caused by RSV infection was reduced in BRP-39 KO mice as compared to WT mice. Th2 cytokine levels were not increased in the lungs of RSV-infected BRP-39 KO mice. BRP-39 regulated M2 macrophage activation in RSV-infected mice. Additionally, treatment with anti-CHI3L1 antibody attenuated airway inflammation and Th2 cytokine production in RSV-infected WT mice. CONCLUSION: These findings suggest that CHI3L1 could contribute to airway inflammation induced by RSV infection. CHI3L1 could be a potential therapeutic candidate for attenuating Th2-associated immunopathology during RSV infection.


Subject(s)
Asthma/virology , Chitinase-3-Like Protein 1/adverse effects , Inflammation/virology , Respiratory Syncytial Virus Infections/complications , Respiratory System/pathology , Animals , Case-Control Studies , Child , Chitinase-3-Like Protein 1/analysis , Cytokines/metabolism , Female , Growth Substances , Humans , Mice , Mice, Inbred C57BL , Respiratory Syncytial Viruses , Respiratory System/virology
3.
BMC Pulm Med ; 14: 143, 2014 Sep 02.
Article in English | MEDLINE | ID: mdl-25178399

ABSTRACT

BACKGROUND: Angiopoietin-1 (Ang-1) is an essential mediator of angiogenesis that establishes vascular integrity, and angiopoietin-2 (Ang-2) acts as its natural inhibitor. We considered that angiopoietin might be important in bronchial asthma. METHODS: In total, 35 patients with asthma and 20 healthy subjects were studied. RESULTS: The serum Ang-1 levels were significantly elevated in patients with asthma compared to control subjects (293.9 ± 13.8 pg/mL vs. 248.3 ± 16.2 pg/mL, respectively, p = 0.04). The serum Ang-2 levels were not different between the two groups. The areas under the curve (AUC) for serum angiopoietins revealed that the serum level of Ang-1 (0.68) was more sensitive and specific than the serum Ang-2 level (0.55) for differentiating between patients with asthma and control subjects. The serum Ang-1/Ang-2 ratio was correlated with the FEV1/FVC ratio (r = -0.312, p = 0.02), while serum Ang-2 was correlated with body mass index. CONCLUSIONS: Our results indicate that the serum Ang-1 levels were higher in asthma patients compared with healthy subjects. As the Ang-1/Ang-2 ratio was related to lung function, the data suggest that serum angiopoietin is associated with lung function in patients with asthma.


Subject(s)
Angiopoietin-1/blood , Angiopoietin-2/blood , Asthma/blood , Adult , Area Under Curve , Asthma/diagnosis , Asthma/physiopathology , Biomarkers/blood , Body Mass Index , Female , Forced Expiratory Volume , Humans , Male , Middle Aged , Retrospective Studies , Sensitivity and Specificity , Vital Capacity
4.
Int J Toxicol ; 33(1): 21-8, 2014.
Article in English | MEDLINE | ID: mdl-24536021

ABSTRACT

Air pollutants and obesity are important factors that contribute to asthma. The aim of this study was to assess the airway responsiveness and inflammation in Otsuka-Long Evans Tokushima Fatty (OLETF) obese rats and Long Evans Tokushima-Otsuka (LETO) nonobese rats exposed to diesel exhaust particles (DEPs). Otsuka Long Evans Tokushima fatty rats and LETO rats were exposed intranasally to DEP and then challenged with aerosolized DEP on days 6 to 8. Body plethysmography, bronchoalveolar lavage (BAL), and histology were performed. Enhanced pause (Penh) was measured as an indicator of airway resistance on day 9 and samples were collected on day 10. After exposure to DEP, the OLETF group exhibited a greater increase in Penh compared to that in the LETO group. Moreover, the BAL fluid in mice showed an increase in the total and differential cell counts in the DEP-exposed OLETF group compared to that in the DEP-exposed LETO group. Histological assessment of lung tissue from each group revealed that the DEP-exposed OLETF group tended to have increased inflammatory cell infiltrations in the prebronchial area. Increased peroxisome proliferator-activated receptor γ, coactivator 1ß messenger RNA was observed in the lungs of obese rats compared to that in nonobese rats following DEP exposure. These data indicate that the DEP-exposed OLETF group had increased airway responses and inflammation compared to the DEP-exposed LETO group, indicating that diesel particulates and obesity may be co-contributors to asthma.


Subject(s)
Airway Resistance/drug effects , Asthma/etiology , Obesity/physiopathology , Particulate Matter/toxicity , Respiratory Mucosa/drug effects , Up-Regulation/drug effects , Vehicle Emissions/toxicity , Animals , Asthma/chemically induced , Bronchial Provocation Tests , Bronchoalveolar Lavage Fluid/chemistry , Bronchoalveolar Lavage Fluid/cytology , Bronchoalveolar Lavage Fluid/immunology , Disease Models, Animal , Eosinophils/drug effects , Eosinophils/immunology , Eosinophils/pathology , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/pathology , Lung/drug effects , Lung/immunology , Lung/metabolism , Lung/pathology , Obesity/immunology , Obesity/pathology , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha , Plethysmography, Whole Body , Rats , Rats, Inbred OLETF , Rats, Long-Evans , Respiratory Mucosa/immunology , Respiratory Mucosa/pathology , Respiratory Mucosa/physiopathology , Specific Pathogen-Free Organisms , Transcription Factors/agonists , Transcription Factors/genetics , Transcription Factors/metabolism
5.
Pulm Pharmacol Ther ; 27(2): 184-9, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24120690

ABSTRACT

Aspirin-exacerbated respiratory disease (AERD) has attracted a great deal of attention because of its association with increased asthma severity. To identify plasma biomarkers for the prediction of AERD, the six most abundant plasma proteins (albumin, IgG, antitrypsin, IgA, transferrin, and haptoglobin) in pooled plasma samples were removed using a multiple affinity removal system column. Two-dimensional gel electrophoresis (2DE) was used for differential display proteomic analysis of the pooled plasma. Proteins were identified by matrix assisted laser desorption ionization time-of-flight (MALDI-TOF)/TOF. Enzyme-linked immunosorbent assay (ELISA) was performed to identify and quantify apolipoprotein H (Apo H) in plasma from subjects with AERD and aspirin-tolerant asthma (ATA). Eight protein spots showed differences in relative intensity between pooled plasma from subjects with AERD (n = 8) and those with ATA (n = 8). MALDI-TOF/TOF analysis showed decreases in the levels of alpha-fibrinogen precursor, Apo H, fibrin beta, and proapolipoprotein in AERD as compared with ATA, and increases in chain A human complement component C3, 90-kDa heat shock protein, complement component C4a, and kininogen-1 isoform 2. Apo H concentrations were significantly increased in plasma from subjects with ATA than those with AERD and normal controls, as measured by ELISA (P < 0.01). AERD is characterized by changes in the levels of proteins involved in the coagulation and complement pathways. In addition, Apo H is up-regulated in ATA compared to AERD and normal controls, suggesting that Apo H may be involved in different pathogenesis of ATA from AERD.


Subject(s)
Aspirin/adverse effects , Asthma, Aspirin-Induced/physiopathology , Asthma/physiopathology , beta 2-Glycoprotein I/blood , Adult , Aged , Aged, 80 and over , Asthma/blood , Asthma, Aspirin-Induced/blood , Biomarkers/metabolism , Case-Control Studies , Electrophoresis, Gel, Two-Dimensional , Enzyme-Linked Immunosorbent Assay , Female , Humans , Male , Middle Aged , Proteomics/methods , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
6.
Korean J Intern Med ; 28(2): 216-23, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23526176

ABSTRACT

BACKGROUND/AIMS: Ozone is an environmentally reactive oxidant, and pycnogenol is a mixture of flavonoid compounds extracted from pine tree bark that have antioxidant activity. We investigated the effects of pycnogenol on reactive nitrogen species, antioxidant responses, and airway responsiveness in BALB/c mice exposed to ozone. METHODS: Antioxidant levels were determined using high performance liquid chromatography with electrochemical detection. Nitric oxide (NO) metabolites in bronchoalveolar lavage (BAL) fluid from BALB/c mice in filtered air and 2 ppm ozone with pycnogenol pretreatment before ozone exposure (n = 6) were quantified colorimetrically using the Griess reaction. RESULTS: Uric acid and ascorbic acid concentrations were significantly higher in BAL fluid following pretreatment with pycnogenol, whereas γ-tocopherol concentrations were higher in the ozone exposed group but were similar in the ozone and pycnogenol pretreatment groups. Retinol and γ-tocopherol concentrations tended to increase in the ozone exposure group but were similar in the ozone and pycnogenol pretreatment groups following ozone exposure. Malonylaldehyde concentrations increased in the ozone exposure group but were similar in the ozone and pycnogenol plus ozone groups. The nitrite and total NO metabolite concentrations in BAL fluid, which parallel the in vivo generation of NO in the airways, were significantly greater in the ozone exposed group than the group exposed to filtered air, but decreased with pycnogenol pretreatment. CONCLUSIONS: Pycnogenol may increase levels of antioxidant enzymes and decrease levels of nitrogen species, suggesting that antioxidants minimize the effects of acute ozone exposure via a protective mechanism.


Subject(s)
Antioxidants/pharmacology , Bronchial Hyperreactivity/prevention & control , Flavonoids/pharmacology , Lung/drug effects , Oxidative Stress/drug effects , Ozone , Animals , Ascorbic Acid/metabolism , Bronchial Hyperreactivity/chemically induced , Bronchial Hyperreactivity/metabolism , Bronchoalveolar Lavage Fluid/chemistry , Bronchoconstriction/drug effects , Disease Models, Animal , Female , Inhalation Exposure , Lung/enzymology , Lung/physiopathology , Malondialdehyde/metabolism , Mice , Mice, Inbred BALB C , Nitric Oxide/metabolism , Plant Extracts , Uric Acid/metabolism , Vitamin A/metabolism , alpha-Tocopherol/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL